Morning Trend | HLI Approaches Resistance Zone, Is a Trading Recovery Coming?

Houlihan Lokey has steadily risen recently, driven by the recovery in the financial services and investment banking sub-sectors, with prices approaching previous resistance levels. After multiple pullbacks during intraday trading, it has chosen to look back, indicating that funds are more inclined towards "steady confirmation" and have not rashly chased higher prices. Market discussions are focused on the narrative of "merger and acquisition recovery and reopening of financing windows": if interest rate expectations become more moderate and the credit environment improves, potential transactions and new case reserves may accelerate release. On the market side, the volume during the upward phase has improved, but to effectively break through the resistance level, more decisive volume and high-level support are still needed. Right-side trading places more emphasis on: first, whether it can stabilize above the resistance after the surge and complete a pullback confirmation the next day; second, the strength of the linkage between large investment banks and boutique advisors in the sector, and whether there is a "collective rise" in funding behavior. Risks need to be assessed simultaneously: if macro data reinforces the expectation of "high rates lasting longer," or if market risk appetite quickly shifts to technology high Beta, the investment banking and advisory sectors may passively retreat; if a surge is followed by a pullback with increased volume, it may easily be interpreted as "the window has not opened." Key observation points include: the resonance of large orders and the brokerage investment banking index, the density of merger and acquisition and refinancing announcements, and the latest guidance from management on project implementation and cost rates. In terms of strategy, prioritize confirmation, and follow up moderately if a breakthrough is achieved and stabilized; if a pullback breaches key support and volume increases, decisively reduce exposure. Overall thinking: recovery expectations are converging, but dual verification from price and data is still needed